← All diseases Infectious diseases

Chronic hepatitis C

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest quality evidence only (79)Meta-analysis (20)Treatment guideline (4)Phase 3 study (27)Randomized trial (14)Systematic review (14)Clinical trial (677)Review article (146)Early study (phase 1 or 2) (11)Case report (85)Laboratory or animal study (8)Commentary or editorial (53)Retracted publication (2) Studies currently recruiting participants only (15)

Filter

Publications and studies (1942)

• Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection. (2019/05/01) ♡
• Strategy and Efficacy of Generic and Pan-genotypic Sofosbuvir/Velpatasvir in Chronic Hepatitis C Virus: A Myanmar Experience. (2019/05/01) ♡
• New direct-acting antivirals for hepatitis C treatment and neuropsychiatric symptoms in psychiatric risk groups. (2019/05/01) ♡
• Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey. (2019/05/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. (2019/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Antioxidants benefits in hepatitis C infection in the new DAAs era. (2019/05/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. (2019/04/06) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pentraxin 3 Detects Clinically Significant Fibrosis in Patients with Chronic Viral Hepatitis C. (2019/04/02) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment. (2019/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Diagnosis of hepatitis C virus infection in Spain: An opportunity to improve. (2019/04/01) ♡
• Neuropsychiatric symptoms in hepatitis C patients resemble those of patients with autoimmune liver disease but are different from those in hepatitis B patients. (2019/04/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Clinical management of patients with hemophilia A in nephrology: Diagnostic and therapeutic challenges illustrated by the cases of 2 patients]. (2019/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Does incarceration change the profile of pulmonary tuberculosis in Tunisia? (2019/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The health equity implementation framework: proposal and preliminary study of hepatitis C virus treatment. (2019/03/12) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Efficacy and safety of alisporivir for the treatment of hepatitis C infection. (2019/03/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals. (2019/03/01) ♡
• microRNA-1273g-3p is a useful non-invasive test for the prediction of liver fibrosis in patients with chronic hepatitis C. (2019/03/01) ♡
• Chronic Hepatitis C and Health-Related Quality of Life in Patients with Cognitive Impairment. (2019/03/01) ♡
• Improving Health-Related Quality of Life Assessment in Chronic Hepatitis C. (2019/03/01) ♡
• Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography. (2019/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Pegylated interferon and ribavirin treatment for chronic hepatitis C deteriorates subclinical markers of vascular function. (2019/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016. (2019/03/01) ♡
• Circulating microRNA-155 is associated with insulin resistance in chronic hepatitis C patients. (2019/03/01) ♡
• Glutathione peroxidase and malondialdehyde in children with chronic hepatitis C. (2019/03/01) ♡
• Clinical and Molecular Risk Factors of Anti-tubercular Therapy Induced Hepatitis. (2019/03/01) ♡
• Mortality among people who inject drugs: Ten-year follow-up of the hepatitis C virus cohort. (2019/03/01) ♡
• Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study. (2019/02/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Non-immunological complications following kidney transplantation. (2019/02/18) ♡
• De Novo Malignancies After Liver Transplantation: A Single Institution Experience. (2019/02/01) ♡
• Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome. (2019/02/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Novel adeno‑associated virus‑based genetic vaccines encoding hepatitis C virus E2 glycoprotein elicit humoral immune responses in mice. (2019/02/01) ♡
• CDR3 repertoire diversity of CD8+ T lymphocytes in patients with HCV. (2019/02/01) ♡
• Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection. (2019/02/01) ♡
• Ribavirin induces widespread accumulation of IMP dehydrogenase into rods/rings structures in multiple major mouse organs. (2019/02/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Was It Worth Introducing Health Economic Evaluation of Innovative Drugs in the French Regulatory Setting? The Case of New Hepatitis C Drugs. (2019/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study. (2019/02/01) ♡
• Insulin/high-density lipoprotein cholesterol ratio: A newly-discovered predictor of esophageal varices in patients with hepatitis C virus-related cirrhosis in the absence of diabetes mellitus. (2019/02/01) ♡
• Sofosbuvir in combination with ribavirin or simeprevir: real-life study of patients with hepatitis C genotype 4. (2019/01/01) ♡
• Efficacy of Direct-acting Antivirals to Improve Clinical Condition, Fibrosis, and Liver Function in Liver Transplant Recipients Infected by Hepatitis C. (2019/01/01) ♡
• Results of Sofosbuvir Plus Ribavirin in Patients With Hepatitis C Related Decompensated Cirrhosis. (2019/01/01) ♡
• Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients. (2019/01/01) ♡
• Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker. (2019/01/01) ♡
• Ritonavir-boosted paritaprevir, ombitasvir plus ribavirin could improve eGFR in patients with renal impairment and HCV: an Egyptian cohort. (2019/01/01) ♡
• Prevalence and sociodemographic disparities of Hepatitis C in Baby Boomers and the US adult population. (2019/01/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL study. (2019/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Glecaprevir/Pibrentasvir Induced Cholestatic Jaundice in a HCV Patient with Renal Failure. A Case Presentation. (2019/01/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Prolactin Induces IL-2 Associated TRAIL Expression on Natural Killer Cells from Chronic Hepatitis C Patients In vivo and In vitro. (2019/01/01) ♡
• Comparative hepatoprotective effect of Nigella sativa pre- and post-treatment to rabbits. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment of hepatitis C in selected clinical settings. (2019/01/01) ♡
• Clinical Encounters and Treatment Initiation for Chronic Hepatitis C Patients: Applications of Adaptive Leadership Framework for Chronic Illness. (2019/01/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.